EU Revokes Intercept/Advanz’s Ocaliva Approval As Moment Of Reckoning Nears in US

 
• By Sue Sutter
  
Wooden blocks
Ocaliva's continued marketing in the EU and US is at risk. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Regional Comparisons

More from Pink Sheet